About 6,330 results

ALLMedicine™ Intravenous Immunoglobulin Center

Research & Reviews  2,281 results

Intravenous immunoglobulin regulates anti-desmoglein 3 IgG production in B220- antibody...
The Journal of Investigative Dermatology; Kase Y, Takahashi H et. al.

Dec 2nd, 2021 - Intravenous immunoglobulin (IVIG) is a treatment option for intractable cases of pemphigus vulgaris (PV), an autoimmune blistering disease caused by autoantibodies against desmoglein 3 (Dsg3). To investigate the efficacy of IVIG on autoantibody se...

Kawasaki Disease in Childhood and Psychiatric Disorders: A Population-Based Case-Contro...
Brain, Behavior, and Immunity; Tzu-Li Chen D, Pei-Chen Chang J et. al.

Dec 2nd, 2021 - Kawasaki disease (KD) is a common childhood acute inflammatory disease and potentially triggers a chronic inflammation. Although some researches have investigated neurodevelopmental consequences following KD, the findings have been inconsistent. T...

Modelling the concentration of anti-SARS-CoV-2 immunoglobulin G in intravenous immunogl...
PloS One; Stinca S, Barnes TW et. al.

Nov 30th, 2021 - Plasma-derived intravenous immunoglobulin (IVIg) products contain a dynamic spectrum of immunoglobulin (Ig) G reactivities reflective of the donor population from which they are derived. We sought to model the concentration of anti-severe acute re...

Eyelid ptosis and muscle weakness in a child with Kawasaki disease: a case report.
https://doi.org/10.1186/s12887-021-02979-4 10.1161/CIR.0000000000000484 10.1097/INF.0b013e3181950b64 10.1016/S0387-7604(85)80120-0 10.1016/0887-8994(90)90048-6 10.1007/s002470050665 10.1007/s12098-015-1709-3 10.1007/s12098-019-03009-z 10.1007/s00296-009-1154-6 10.1159/000357258
BMC Pediatrics; Lin Y, Wang L et. al.

Nov 29th, 2021 - Kawasaki disease (KD) is an acute febrile vasculitis that often occurs in children under 5 years. Ptosis and muscle weakness associated with KD are rarely documented. We present a case of KD with eyelid ptosis and muscle weakness in a 3-year-old b...

see more →

Guidelines  2 results

European Guidelines (S1) on the use of high-dose intravenous immunoglobulin in dermatol...
Journal of the European Academy of Dermatology and Venere... Enk AH, Hadaschik EN et. al.

Oct 21st, 2016 - The treatment of severe dermatological autoimmune diseases and toxic epidermal necrolysis (TEN) with high-dose intravenous immunoglobulin (IVIg) is a well-established procedure in dermatology. As treatment with IVIg is usually considered for rare ...

European Federation of Neurological Societies/Peripheral Nerve Society guideline on man...
European Journal of Neurology; Van den Bergh PY, Hadden RD et. al.

May 12th, 2010 - Consensus guidelines on the definition, investigation, and treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) have been previously published in European Journal of Neurology and Journal of the Peripheral Nervous System. ...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  65 results

IVIG Versus Plasmapheresis in the Treatment of Guillian Barrie Syndrome Patients

Nov 3rd, 2021 - Guillain-Barré syndrome (GBS) is an inflammatory disease of the PNS and is the most common cause of acute flaccid paralysis, with an annual global incidence of approximately 1-2 per 100,000 person-years. Patients with GBS typically present with we...

Post IVIG Medication in Children With Immune Thrombocytopenia

Oct 25th, 2021 - Immune thrombocytopenia (ITP) is the most common acquired immune cytopenia in childhood, affecting 4-6 in 100,000 children. The pathophysiology of ITP is highly complex and incompletely understood. Accepted mechanisms include immune dysregulation ...

A Study to Investigate DSA Rebound in Patients Treated With Imlifidase Prior to Transplantation

Sep 20th, 2021 - Imlifidase is an immunoglobulin G (IgG)-degrading enzyme of Streptococcus pyogenes that is highly specific for IgG. The cleavage of IgG generates one F(ab')2- and one homodimeric Fc-fragment and efficiently neutralizes Fc-mediated activities of Ig...

Anti COVID 19 Hyperimmune Intravenous Immunoglobulin (C-IVIG) Therapy for Severe COVID-19 Patients

Aug 24th, 2021 - Research team at Dow University of Health Sciences has purified immunoglobulin (both SARS-CoV 2 antibodies and existing antibodies) from convalescent plasma of COVID19 individuals and pooled to prepared IVIG formulation to treat severe and critica...

Cyclosporine vs Steroids in DRESS

Aug 3rd, 2021 - Current treatments for patients with drug reaction with eosinophilia and systemic symptoms (DRESS) include supportive care, steroids, cyclosporine and to a lesser extent, intravenous immunoglobulin (IVIG). Regarding IVIG, a recent case series sugg...

see more →

News  181 results

CNS Autoimmunity After COVID in Teens?

Nov 11th, 2021 - Recent research suggests that some pediatric patients who develop neuropsychiatric symptoms from COVID-19 may have intrathecal antineural SARS-CoV-2 autoantibodies, which may hint at central nervous system (CNS) autoimmunity in these patients. "Ov...

Infliximab Bests Second IVIG Infusion in Refractory Kawasaki Disease

Nov 9th, 2021 - NEW YORK (Reuters Health) - In children with intravenous immunoglobulin (IVIG)-resistant Kawasaki disease (KD), infliximab was safe and more effective than a second IVIG infusion in resolving fever, decreasing hospital length of stay, and reducing...

Dupilumab Eases Skin and GI Symptoms of Rare Immunodeficiency Syndrome

Aug 24th, 2021 - NEW YORK (Reuters Health) - Dupilumab appears to be effective not only for the skin inflammation but also the gastrointestinal symptoms related to STAT3 hyper-immunoglobulin E syndrome (STAT3-HIES), report clinicians from Taiwan. "STAT3-HIES is a ...

PI-Based Combinations for Relapsed Myeloma

Aug 17th, 2021 - Keith Stewart, MD, ChB, MBA: Nina, let’s stay with you. I’ve always thought since both carfilzomib and daratumumab came along that it shouldn’t be one or the other. It should be both because they’re such incredibly powerful drugs in myeloma. We ha...

Infusion shown effective for acquired von Willebrand disease
Mark S. Lesney, PhD

Aug 10th, 2021 - Acquired von Willebrand disease (aVWD) is a rare and serious condition associated with lymphoproliferative disorders, malignancy, autoimmune disorders, and cardiovascular disease. It is most commonly caused by monoclonal gammopathy of undetermined.

see more →

Patient Education  2 results see all →